IR@PKUHSC  > 北京大学深圳医院  > 泌尿外科
学科主题临床医学
Investigating urachal carcinoma for more than 15 years
Chen, Duqun1,2,3; Li, Yifan1,2,3; Yu, Zuhu1,2,3; Su, Zhengming2,3,4; Ni, Liangchao2,3; Gui, Yaoting2,3; Yang, Shangqi2,3; Shi, Bentao2,3,5; Lai, Yongqing2,3
关键词urachal carcinoma survival tumor grade
刊名ONCOLOGY LETTERS
2014-11-01
DOI10.3892/ol.2014.2502
8期:5页:2279-2283
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]SURVIVAL ; OUTCOMES ; CANCER
英文摘要

Urachal carcinomas are rare bladder malignances, which usually present at an advanced stage with a high risk of distant metastases and a poor prognosis. To improve understanding of this uncommon carcinoma, a retrospective review was conducted for the cases observed at Peking University Shenzhen Hospital and Peking University First Hospital. The clinical outcomes were analyzed for 17 patients with a diagnosis of urachal cancer, who were admitted to Peking University Shenzhen Hospital (Shenzhen, China) and Peking University First Hospital (Beijing, China) between 1998 and 2013. The TNM staging system was used to predict outcomes. Among the 17 study patients, there were 10 males and seven females, with a median age at diagnosis of 50 years. A total of four (23%) patients presented with lymph node or distant metastasis. The median overall survival time for all stages was 57.6 months, with five patients (38.4%) alive for more than five years following treatment. The application of the TNM staging system demonstrated a median survival time of 6.2 years for stage I/II patients, compared with a median survival of 1.8 years (log-rank, P<0.001) for patients with advanced disease (stages III and IV). In addition, no significant correlation was observed between tumor size and age, and survival. In conclusion, urachal carcinomas are usually locally advanced at presentation. Surgical excision remains the predominant choice of treatment and lymph node dissection is not required unless lymph node involvement is confirmed by preoperative examination. The current results indicated that the most significant predictor of prognosis was the tumor grade.

语种英语
WOS记录号WOS:000344424300072
项目编号81101922 ; A2012584 ; A2013606 ; JCYJ20130402114702124
资助机构National Natural Science Foundation of China ; Medical Scientific Research Foundation of Guangdong Province of China ; Science and Technology Development Fund Project of Shenzhen
引用统计
被引频次:9[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/66839
专题北京大学深圳医院_泌尿外科
北京大学第一临床医学院_泌尿外科
作者单位1.Anhui Med Univ, Dept Urol, Hefei 230032, Anhui, Peoples R China
2.Peking Univ, Shenzhen Hosp, Dept Urol, Shenzhen 518036, Guangdong, Peoples R China
3.Peking Univ, Shenzhen Hosp, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen PKU HKUST Med Ctr,Inst Urol, Shenzhen 518036, Guangdong, Peoples R China
4.Shantou Univ, Coll Med, Dept Urol, Shantou 515041, Guangdong, Peoples R China
5.Peking Univ, Inst Urol, Dept Urol, Hosp 1, Beijing 100034, Peoples R China
推荐引用方式
GB/T 7714
Chen, Duqun,Li, Yifan,Yu, Zuhu,et al. Investigating urachal carcinoma for more than 15 years[J]. ONCOLOGY LETTERS,2014,8(5):2279-2283.
APA Chen, Duqun.,Li, Yifan.,Yu, Zuhu.,Su, Zhengming.,Ni, Liangchao.,...&Lai, Yongqing.(2014).Investigating urachal carcinoma for more than 15 years.ONCOLOGY LETTERS,8(5),2279-2283.
MLA Chen, Duqun,et al."Investigating urachal carcinoma for more than 15 years".ONCOLOGY LETTERS 8.5(2014):2279-2283.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Chen, Duqun]的文章
[Li, Yifan]的文章
[Yu, Zuhu]的文章
百度学术
百度学术中相似的文章
[Chen, Duqun]的文章
[Li, Yifan]的文章
[Yu, Zuhu]的文章
必应学术
必应学术中相似的文章
[Chen, Duqun]的文章
[Li, Yifan]的文章
[Yu, Zuhu]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。